BR112016027504B1 - Composição e método para estabilizar um substrato luminogênico e kit que compreende a referida composição - Google Patents
Composição e método para estabilizar um substrato luminogênico e kit que compreende a referida composição Download PDFInfo
- Publication number
- BR112016027504B1 BR112016027504B1 BR112016027504-7A BR112016027504A BR112016027504B1 BR 112016027504 B1 BR112016027504 B1 BR 112016027504B1 BR 112016027504 A BR112016027504 A BR 112016027504A BR 112016027504 B1 BR112016027504 B1 BR 112016027504B1
- Authority
- BR
- Brazil
- Prior art keywords
- att
- tak
- composition
- triazin
- fact
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent materials, e.g. electroluminescent or chemiluminescent
- C09K11/06—Luminescent materials, e.g. electroluminescent or chemiluminescent containing organic luminescent materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Electroluminescent Light Sources (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462002363P | 2014-05-23 | 2014-05-23 | |
| US62/002,363 | 2014-05-23 | ||
| PCT/US2015/032439 WO2015179864A1 (en) | 2014-05-23 | 2015-05-26 | Compositions and methods for stabilizing luminogenic substrates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112016027504A2 BR112016027504A2 (cg-RX-API-DMAC7.html) | 2017-08-15 |
| BR112016027504B1 true BR112016027504B1 (pt) | 2023-04-18 |
Family
ID=53434457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016027504-7A BR112016027504B1 (pt) | 2014-05-23 | 2015-05-26 | Composição e método para estabilizar um substrato luminogênico e kit que compreende a referida composição |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9676997B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3146066B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6641297B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102456212B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN106661028B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015263901B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112016027504B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2949447C (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201609382WA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015179864A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3661932B1 (en) | 2017-08-04 | 2021-10-06 | Promega Corporation | Compositions and methods for stabilizing benzothiazole luciferin analogs |
| IL318819A (en) | 2018-10-03 | 2025-04-01 | Promega Corp | Compounds and methods for stabilizing cholinetyrazine and its derivatives |
| CN111116594B (zh) * | 2019-12-03 | 2021-05-28 | 山东大学 | 一种C-6位改造NanoLuc类型类似物及其制备方法与应用 |
| CN121399275A (zh) * | 2024-05-21 | 2026-01-23 | 深圳琅技生命科技有限公司 | 用于稳定腔肠素及其类似物的组合物及方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2000622A1 (de) * | 1970-01-08 | 1971-07-22 | Agfa Gevaert Ag | Verfahren zur Stabilisierung von Silberbildern |
| JP4639904B2 (ja) * | 2005-03-30 | 2011-02-23 | チッソ株式会社 | 蛍光活性を有するルシフェラーゼの活性増強方法 |
| JP4761150B2 (ja) * | 2006-07-24 | 2011-08-31 | 独立行政法人産業技術総合研究所 | ハイスループット発光活性測定のためのセレンテラジン(ウミシイタケルシフェリン)溶液の安定化組成物および安定化法 |
| US7718389B2 (en) * | 2006-07-24 | 2010-05-18 | National Institute Of Advanced Industrial Science And Technology | Stabilizing composition and stabilizing method of coelenterazine solution for high-throughput measurement of luciferase activity |
| EP2626703B1 (en) * | 2008-03-27 | 2017-05-03 | Promega Corporation | Protein labeling with cyanobenzothiazole conjugates |
| CN103443121B (zh) | 2010-11-02 | 2016-04-20 | 普罗梅加公司 | 新型腔肠素底物及其使用方法 |
-
2015
- 2015-05-26 EP EP15730321.5A patent/EP3146066B1/en active Active
- 2015-05-26 CN CN201580026864.3A patent/CN106661028B/zh active Active
- 2015-05-26 KR KR1020167033229A patent/KR102456212B1/ko active Active
- 2015-05-26 CA CA2949447A patent/CA2949447C/en active Active
- 2015-05-26 SG SG11201609382WA patent/SG11201609382WA/en unknown
- 2015-05-26 JP JP2016569444A patent/JP6641297B2/ja active Active
- 2015-05-26 US US14/721,727 patent/US9676997B2/en active Active
- 2015-05-26 WO PCT/US2015/032439 patent/WO2015179864A1/en not_active Ceased
- 2015-05-26 BR BR112016027504-7A patent/BR112016027504B1/pt active IP Right Grant
- 2015-05-26 AU AU2015263901A patent/AU2015263901B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3146066B1 (en) | 2018-03-14 |
| WO2015179864A1 (en) | 2015-11-26 |
| BR112016027504A2 (cg-RX-API-DMAC7.html) | 2017-08-15 |
| SG11201609382WA (en) | 2016-12-29 |
| AU2015263901A1 (en) | 2016-11-24 |
| JP2017519977A (ja) | 2017-07-20 |
| KR102456212B1 (ko) | 2022-10-20 |
| US20150337198A1 (en) | 2015-11-26 |
| CN106661028B (zh) | 2021-08-06 |
| US9676997B2 (en) | 2017-06-13 |
| CA2949447A1 (en) | 2015-11-26 |
| EP3146066A1 (en) | 2017-03-29 |
| AU2015263901B2 (en) | 2021-03-11 |
| JP6641297B2 (ja) | 2020-02-05 |
| CA2949447C (en) | 2022-10-04 |
| CN106661028A (zh) | 2017-05-10 |
| KR20170012271A (ko) | 2017-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2949447C (en) | Compositions and methods for stabilizing luminogenic substrates | |
| ES2549031T3 (es) | Compuestos marcadores de bifenil bencil éter para hidrocarburos líquidos y otros combustibles y aceites | |
| Sanderson | Radical reorganization and bond energies in organic molecules | |
| Zhilin et al. | Novel arylazo‐1, 2, 5‐oxadiazole photoswitches: synthesis, photoisomerization and nitric oxide releasing properties | |
| Osmaniye et al. | Design, synthesis and biological evaluation of new N‐acyl hydrazones with a methyl sulfonyl moiety as selective COX‐2 inhibitors | |
| Becker et al. | Selective Modification for Red‐Shifted Excitability: A Small Change in Structure, a Huge Change in Photochemistry | |
| EP3661932B1 (en) | Compositions and methods for stabilizing benzothiazole luciferin analogs | |
| Karaman et al. | Design and evaluation of biological activities of 1, 3‐oxazolidinone derivatives bearing amide, sulfonamide, and thiourea moieties | |
| Szilágyi et al. | Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors | |
| Bao et al. | Determination and analysis of solubility of 5-bromo-7-azaindole in pure and mixed solvent systems at different temperatures (T= 278.15–323.15 K) | |
| Saeed et al. | Design, Synthesis, and Antibacterial, Antifungal, and Antioxidant Activities of New Four Membered Rings from Derivatives Containing a 4 (3 H)-Quinazolinone Moiety, Activities | |
| Venkateswararao et al. | Exploration and Optimization of an Efficient One‐pot Sequential Synthesis of Di/tri‐substituted Thiazoles from α‐Bromoketones, Thioacids Salt, and Ammonium Acetate | |
| FI73436C (fi) | Foerfarande foer framstaellning av som laekemedel anvaendbara rifamyciner. | |
| Syed et al. | Design and Development of Distinct Tetracyanoquinodimethane Derivatives Exhibiting Dual Effect of Fluorescence and Anticancer Activity | |
| Claus et al. | Conformational preference of the sulfimide functionality in cyclic sulfimides | |
| Sicak et al. | Synthesis, characterization, and antioxidant and anticholinesterase activities of pyrazolo derivatives | |
| JP6932082B2 (ja) | ルシフェリンの安定化方法及び生物発光の測定方法 | |
| Doherty et al. | 4‐Aza Cyclopentenone Prostaglandin Analogues: Synthesis and NF‐κB Inhibitory Activities | |
| Kambale et al. | Ultrasound-assisted, green and efficient synthesis of ferrocene-appended azo-phenothiazines | |
| Gashkova et al. | Synthesis and Antiarrhythmic and Hemostatic Activity of [3, 3-Dialkyl-3, 4-Dihydroisoquinolin-1 (2 H)-Ylidene]-N-Alkylacetamides | |
| Tariq et al. | Synthesis and Characterization of New 1, 2, 4-Triazole Derivative Form Methylbenzoate with Sulfur as Bridge Links. | |
| Shindy et al. | Effects of chemical structure, solvent and solution pH on the visible spectra of some new methine cyanine dyes | |
| Kumar et al. | Synthesis and biological evaluation of 1, 3, 4-oxadiazole linked azaindole derivatives as anticancer agents | |
| Semenok et al. | Experimental Evidence of Intramolecular CAr–H··· O= C Hydrogen Bonds in the Structure of (Diaryl) tetrahydrofuranones Using Spectroscopic Tools | |
| Keum et al. | Diastereomeric isomerization of Fischer's base analogs of LTAM molecules in organic solvents: mechanistic investigation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/05/2015, OBSERVADAS AS CONDICOES LEGAIS |